Press Releases
Press Releases
European Medicines Agency accepted Sandozs biosimilar rituximab regulatory submission
Sandoz advances biosimilar portfolio with sixth major biosimilar file acceptance in less than one yearSandoz is seeking approval for all indications included in the reference...
Press Releases
FDA Expands Indication of INVOKAMET (canagliflozin/metformin HCl) to Include First-Line Treatment of
Janssen Pharmaceuticals, Inc. announced the U.S. FDA has approved INVOKAMET, a fixed-dose combination therapy of INVOKANA® (canagliflozin) and metformin hydrochloride, for first-line treatment of adults...
Press Releases
Point-of-care ultrasound indispensable for elite sport in Wales
Point-of-care ultrasound is an essential tool for Dr Mark Ridgewell, an early pioneer for sports and exercise medicine (SEM) and, for the past 13 years,...
Press Releases
Varian Medical Systems Announces Plan To Spin Off Imaging Components Business
Imaging Components business will become a new independent publicly traded company, which will be spun off by means of a tax-free distribution to Varian stockholdersSpin-off...
Press Releases
Novartis’ Entresto given strong Class I recommendation in both US and EU heart failure guidelines, l
US guidelines now recommend Entresto as standard of care for HFrEF as an alternative to ACEs or ARBs; call for doctors to switch patients...
Press Releases
FDA approves Boston Scientific Precision Montage™ MRI Spinal Cord Stimulator System
Boston Scientific Corporation announced the launch of the Precision Montage™ MRI Spinal Cord Stimulator (SCS) System after receiving approval from the U.S. Food and Drug...
Press Releases
Novartis starts FortiHFy clinical program to study heart failure
Fortifying Heart Failure clinical evidence and patient quality of life (FortiHFy) is an umbrella clinical program comprising over 40 active or planned trials
The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.